Clinical trial
Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or…
NCT00176488 · University of Medicine and Dentistry of New Jersey, Other · Terminated
Key facts
| NCT number | NCT00176488 |
|---|---|
| Title | Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer |
| Official title | A Phase II Trial of Sequential Epirubicin/Vinorelbine in Patients With Advanced Breast Cancer |
| Lead sponsor | University of Medicine and Dentistry of New Jersey, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | epirubicin, vinorelbine |
| Enrollment | 31 |
| Start date | Jun 1, 2003 |
| Primary completion | Oct 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Sep 15, 2005 |
| Last update posted | Mar 23, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: